6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow CT: new trials by email Literature Review of CT trials Research Report on CT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer Computed Tomography, Gallium Ga 68 Gozetotide, Positron Emission Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 3 | Completed | Mayo Clinic | 163 | 2022-05-09 | 2025-07-18 |
| Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Multiple Myeloma | Phase 3 | Completed | National Cancer Institute (NCI) | 1 | 2022-02-16 | 2025-05-23 |
| Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Capecitabine - Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 546 | 2010-04-05 | 2026-02-23 |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Cisplatin, Computed Tomography, Doxorubicin Hydrochloride - Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 235 | 2009-10-28 | 2024-01-03 |
| Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody 124-Iodine-cG250 (124I-cG250), CT - Renal Cell Carcinoma, Kidney Cancer | Phase 3 | Completed | Heidelberg Pharma AG | 226 | 2008-03-01 | 2018-10-02 |
| Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Chest Radiography - Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor | Phase 3 | Completed | Children's Oncology Group | 808 | 2006-11-06 | 2026-06-03 |
Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Kidney Neoplasms (1) · Multiple Myeloma (1) · Neoplasms (1) · Pancreatic Intraductal Neoplasms (1) · Prostatic Neoplasms (1) · Wilms Tumor (1)
National Cancer Institute (NCI) (3) · Children's Oncology Group (1) · Heidelberg Pharma AG (1) · Mayo Clinic (1)
United States (6) · Canada (2) · Israel (2) · Puerto Rico (2) · Australia (1) · Belgium (1) · New Zealand (1) · Switzerland (1)
Al B Benson (1) · Chaitanya Divgi, MD (1) · Elizabeth A Mullen (1) · Geoffrey B. Johnson, M.D., Ph.D. (1) · Ross A Abrams (1) · Shaji K Kumar (1)
PMID 23213092, PMID 27811504, PMID 29211618, PMID 31449468, PMID 33370024, PMID 37222189, PMID 37598723, PMID 38131628, PMID 42456089
U10CA180820 (2), U10CA021115 (1), U10CA021661 (1), U10CA098543 (1), U10CA180830 (1), U10CA180868 (1), U10CA180886 (1)